Metformin Bluefish

Metformin Hydrochloride, the active ingredient in Metformin Bluefish, is a biguanide presented as an oral tablet for oral administration. It lowers elevated blood glucose by targeting hepatic glucose production and enhancing peripheral insulin sensitivity, and is indicated for adults with type 2 diabetes mellitus and is commonly prescribed as part of a comprehensive diabetes management plan.

GNH USA supplies Metformin Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing sourcing, regulatory documentation, and logistics support to meet global procurement needs. The company adheres to stringent quality standards and offers competitive pricing for bulk orders.

Metformin Bluefish is a biguanide antidiabetic medication used to manage glucose metabolism disorders.

- Type 2 diabetes mellitus: improves glycemic control by reducing hepatic glucose output and increasing peripheral glucose uptake.

Metformin Bluefish may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycemia: when combined with other glucose‑lowering agents. - Hepatic dysfunction: elevated liver enzymes. - Allergic reactions: rash, pruritus, or angioedema. - Hemolytic anemia: in patients with G6PD deficiency. - Pancreatitis: inflammation of the pancreas.

Metformin Bluefish requires careful patient assessment and monitoring to minimize risks.

- Renal function: assess creatinine clearance before initiating and periodically thereafter. - Hepatic function: evaluate liver enzymes, especially in patients with liver disease. - Age: start at lower dose in elderly patients to reduce gastrointestinal intolerance. - Alcohol use: advise patients to limit intake to avoid lactic acidosis. - Concomitant drugs: review for agents that may affect renal clearance. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Metformin Bluefish can interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: risk of acute renal failure and lactic acidosis. - Cimetidine: may increase metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis. - Nitrates: may enhance hypotensive effects. - Digoxin: potential for increased serum levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal function and metformin clearance. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - Warfarin: may alter INR, requiring closer monitoring. - Oral contraceptives: may affect glucose tolerance.